More than two billion people worldwide live with metabolic and cardiovascular diseases, including nearly one billion living with obesity. As global populations age, the burden…
The U.S. Food and Drug Administration has accepted two Abbreviated New Drug Applications (ANDAs) from Sandoz for proposed generic tirzepatide autoinjectors. Developed entirely in-house, the…
July 15, 2026
Gated Content
Sign up to get access​
"*" indicates required fields
Sign up to get access
Please provide accurate and verifiable contact information to ensure proper use of our materials and prevent misuse. Thank you for your understanding!